TCR2 THERAPEUTICS INC. Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TCR2 THERAPEUTICS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TCR2 THERAPEUTICS INC. for December 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 26 2019 | TCRR | TCR2 THERAPEUTICS ... | Baeuerle Patrick | Director | Sell | S | 15.44 | 84,907 | 1,310,964 | 350,786 | 435.7 K to 350.8 K (-19.49 %) |
Dec 26 2019 | TCRR | TCR2 THERAPEUTICS ... | Baeuerle Patrick | Director | Sell | S | 15.16 | 32,022 | 485,454 | 435,693 | 467.7 K to 435.7 K (-6.85 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 16.10 | 5,000 | 80,500 | 5,000 | |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Cardama Alfonso Quintas | Chief Medical Offic ... | Option Exercise | A | 16.10 | 72,100 | 1,160,810 | 72,100 | |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Menzel Garry E | President and CEO | Option Exercise | A | 16.10 | 168,000 | 2,704,800 | 168,000 | |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Allen Andrew R | Director | Option Exercise | A | 16.10 | 5,000 | 80,500 | 5,000 | |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Somaiya Mayur Ian | Chief Financial Off ... | Option Exercise | A | 16.10 | 50,000 | 805,000 | 50,000 | |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Hofmeister Robert | Chief Scientific Of ... | Option Exercise | A | 16.10 | 50,000 | 805,000 | 50,000 | |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | J | 0.00 | 13,847 | 0 | 161,024 | 174.9 K to 161 K (-7.92 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | J | 0.00 | 586,153 | 0 | 713,723 | 1.3 M to 713.7 K (-45.09 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 16.47 | 35,323 | 581,819 | 155,986 | 191.3 K to 156 K (-18.46 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 16.47 | 6,642 | 109,403 | 82,575 | 89.2 K to 82.6 K (-7.44 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 2,433 | 41,376 | 191,309 | 193.7 K to 191.3 K (-1.26 %) |
Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.01 | 458 | 7,789 | 89,217 | 89.7 K to 89.2 K (-0.51 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 4,153 | 73,311 | 1,299,876 | 1.3 M to 1.3 M (-0.32 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 1,054 | 18,606 | 330,238 | 331.3 K to 330.2 K (-0.32 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 1,381 | 24,378 | 432,319 | 433.7 K to 432.3 K (-0.32 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 1,155 | 20,389 | 361,665 | 362.8 K to 361.7 K (-0.32 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 30,475 | 537,067 | 1,304,029 | 1.3 M to 1.3 M (-2.28 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 7,741 | 136,421 | 331,292 | 339 K to 331.3 K (-2.28 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 10,135 | 178,611 | 433,700 | 443.8 K to 433.7 K (-2.28 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.62 | 8,479 | 149,427 | 362,820 | 371.3 K to 362.8 K (-2.28 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 75,067 | 1,325,015 | 1,334,504 | 1.4 M to 1.3 M (-5.33 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 19,070 | 336,606 | 339,033 | 358.1 K to 339 K (-5.33 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 24,966 | 440,677 | 443,835 | 468.8 K to 443.8 K (-5.33 %) |
Dec 11 2019 | TCRR | TCR2 THERAPEUTICS ... | Jovan-Embiricos Morana | 10% Owner | Sell | S | 17.65 | 20,886 | 368,661 | 371,299 | 392.2 K to 371.3 K (-5.33 %) |